Biodegradable photoluminescent polymers
US-9145467-B2 · Sep 29, 2015 · US
US9611354B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9611354-B2 |
| Application number | US-201514863889-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 24, 2015 |
| Priority date | Jun 20, 2008 |
| Publication date | Apr 4, 2017 |
| Grant date | Apr 4, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Biodegradable photoluminescent polymer (BPLP) which comprises an oligomer synthesized from a multifunctional monomer, a diol, and an amino acid by reacting (i) a multifunctional monomer comprising citric acid or triethyl citrate with (ii) a diol to form a reaction product, and further reacting the reaction product with (iii) an amino acid, wherein the amino acid is linked as a side group to the oligomer backbone. The BPLP of the present invention poses tunable fluorescence emission characteristics and are cell-compatible and biodegradable. The BPLP can serve as both implant materials and bioimaging probes.
Opening claim text (preview).
The invention claimed is: 1. A polymer composition comprising: an oligomer synthesized from monomers comprising (i) a multifunctional monomer comprising citric acid or triethyl citrate, (ii) a diol, and (iii) an amino acid, wherein the amino acid is linked as a side group to the oligomer backbone. 2. The composition of claim 1 , wherein the diol is selected from 1,8-octanediol, ethylene glycol, propylene glycol, poly(ethylene glycol), polypropylene glycol), 1,3-propanediol, ethanediol, and cis-1,2-cyclohexanediol. 3. The composition of claim 1 , wherein the amino acid comprises alanine, arginine, asparagine, aspartic acid, cysteine, glycine, glutamine, glutamic acid, histidine, isoleucine, leucine, lysine, methionine, proline, phenylalanine, serine, threonine, tyrosine, tryptophan, valine, or a combination thereof. 4. The composition of claim 1 , wherein the amino acid comprises an L-amino acid, D-amino acid, D,L-amino acid, or a derivative thereof. 5. The composition of claim 1 , wherein an acid anhydride or a multifunctional acid chloride is used in addition to the citric acid or triethyl citrate. 6. The composition of claim 1 , wherein maleic acid, maleic anhydride, fumaric acid, fumaryl chloride, acryloylchloride, itaconic acid, or allylmalonic acid is used in addition to the citric acid or triethyl citrate. 7. The composition of claim 1 , wherein the oligomer is crosslinked. 8. A composition comprising: an oligomer synthesized from monomers comprising (i) a multifunctional monomer comprising citric acid or triethyl citrate, (ii) a diol, (iii) an amino acid, and (iv) a di-isocyanate wherein the amino acid is linked as a side group to the oligomer backbone. 9. The composition of claim 8 , wherein the multifunctional monomer comprises citric acid. 10. The composition of claim 8 , wherein the diol is selected from 1,8-octanediol, ethylene glycol, propylene glycol, poly(ethylene glycol), poly(propylene glycol), 1,3-propanediol, ethanediol, and cis-1,2-cyclohexanediol. 11. The composition of claim 8 , wherein the amino acid comprises alanine, arginine, asparagine, aspartic acid, cysteine, glycine, glutamine, glutamic acid, histidine, isoleucine, leucine, lysine, methionine, proline, phenylalanine, serine, threonine, tyrosine, tryptophan, valine, or a combination thereof. 12. The composition of claim 8 , wherein the amino acid comprises an L-amino acid, D-amino acid, D,L-amino acid, or a derivative thereof. 13. The composition of claim 8 , wherein the multifunctional monomer comprises citric acid, the diol comprises 1,8-octanediol, the amino acid comprises cysteine or serine, and the di-isocyanate comprises hexamethylene-1,6-di-isocyanate or 1,4-butane-di-isocyanate. 14. A method of making a crosslinked urethane-doped biodegradable photoluminescent polyester (CUBPLP) comprising: mixing (i) a multifunctional monomer comprising citric acid or triethyl citrate and (ii) a diol to form a mixture; raising the temperature of the mixture to melt the mixture; lowering the temperature of the mixture with stirring to form an oligomer; adding an amino acid to the oligomer with stirring to form a pre-BPLP-amino acid; purifying the pre-BPLP-amino acid; dissolving the purified pre-BPLP-amino acid to form a solution; adding a di-isocyanate to the pre-BPLP-amino acid solution to form a pre-CUBPLP (UBPLP); casting a film of the pre-CUBPLP (UBPLP); and drying the pre-CUBPLP (UBPLP) film to obtain the CUBPLP. 15. The method of claim 14 , wherein the diol is selected from 1,8-octanediol, ethylene glycol, propylene glycol, poly(ethylene glycol), poly(propylene glycol), 1,3-propanediol, ethanediol, and cis-1,2-cyclohexanediol. 16. The method of claim 14 , wherein the multifunctional monomer comprises citric acid, the diol comprises 1,8-octanediol, the amino acid comprises cysteine or serine, and the di-isocyanate comprises hexamethylene-1,6-di-isocyanate or 1,4-butane-di-isocyanate. 17. The method of claim 14 , wherein purifying the pre-BPLP-amino acid comprises: adding the pre-BPLP-amino acid to deionized water; collecting an undissolved pre-BPLP-amino acid portion from the deionized water; and lyophilizing the collected pre-BPLP-amino acid to obtain purified pre-BPLP-amino acid. 18. The method of claim 14 , wherein dissolving the purified pre-BPLP-amino acid to form a solution comprises dissolving the purified pre-BPLP-amino acid in 1,4-dioxane. 19. The method of claim 14 , wherein the film of the pre-CUBPLP (UBPLP) is cast in a laminar airflow. 20. The method of claim 14 , wherein forming the pre-BPLP-amino acid solution further comprises adding one or more catalysts to the solution, the one or more catalysts being selected from tin octanoate, dibutyl tin dilaurate, and 1,4-diazabicyclo[2.2.2]octane.
derived from polycarboxylic acids and polyhydroxy compounds · CPC title
derived from polycarboxylic acids and polyhydroxy compounds · CPC title
Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title
Polyesters derived from hydroxy carboxylic acids, e.g. lactones (C08J2367/06 takes precedence) · CPC title
Vascular smooth muscle cells; 3D culture thereof, e.g. models of blood vessels · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.